Receptor-ligand interaction between CD44 and osteopontin (Eta-1) - PubMed (original) (raw)
Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
G F Weber et al. Science. 1996.
Abstract
The CD44 family of surface receptors regulates adhesion, movement, and activation of normal and neoplastic cells. The cytokine osteopontin (Eta-1), which regulates similar cellular functions, was found to be a protein ligand of CD44. Osteopontin induces cellular chemotaxis but not homotypic aggregation, whereas the inverse is true for the interaction between CD44 and a carbohydrate ligand, hyaluronate. The different responses of cells after CD44 ligation by either osteopontin or hyaluronate may account for the independent effects of CD44 on cell migration and growth. This mechanism may also be exploited by tumor cells to promote metastasis formation.
Similar articles
- Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I, Matsuno S. Harada N, et al. Int J Cancer. 2001 Jan 1;91(1):67-75. doi: 10.1002/1097-0215(20010101)91:1<67::aid-ijc1011>3.0.co;2-d. Int J Cancer. 2001. PMID: 11149422 - Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathy.
Sano N, Kitazawa K, Sugisaki T. Sano N, et al. Nephron. 2001 Dec;89(4):416-21. doi: 10.1159/000046113. Nephron. 2001. PMID: 11721159 - CD44 is not an adhesive receptor for osteopontin.
Smith LL, Greenfield BW, Aruffo A, Giachelli CM. Smith LL, et al. J Cell Biochem. 1999 Apr 1;73(1):20-30. doi: 10.1002/(sici)1097-4644(19990401)73:1<20::aid-jcb3>3.0.co;2-3. J Cell Biochem. 1999. PMID: 10088720 - Interaction between CD44 and osteopontin as a potential basis for metastasis formation.
Weber GF, Ashkar S, Cantor H. Weber GF, et al. Proc Assoc Am Physicians. 1997 Jan;109(1):1-9. Proc Assoc Am Physicians. 1997. PMID: 9010911 Review. - The metastasis gene osteopontin: a candidate target for cancer therapy.
Weber GF. Weber GF. Biochim Biophys Acta. 2001 Dec 28;1552(2):61-85. doi: 10.1016/s0304-419x(01)00037-3. Biochim Biophys Acta. 2001. PMID: 11825687 Review.
Cited by
- Overcoming Irinotecan Resistance by Targeting Its Downstream Signaling Pathways in Colon Cancer.
Saurav S, Karfa S, Vu T, Liu Z, Datta A, Manne U, Samuel T, Datta PK. Saurav S, et al. Cancers (Basel). 2024 Oct 15;16(20):3491. doi: 10.3390/cancers16203491. Cancers (Basel). 2024. PMID: 39456585 Free PMC article. - Leveraging single-cell transcriptomic data to uncover immune suppressive cancer cell subsets in triple-negative canine breast cancers.
Kim MC, Borcherding N, Song WJ, Kolb R, Zhang W. Kim MC, et al. Front Vet Sci. 2024 Sep 23;11:1434617. doi: 10.3389/fvets.2024.1434617. eCollection 2024. Front Vet Sci. 2024. PMID: 39376916 Free PMC article. - Combined proteomics and metabolomics analysis reveal the effect of a training course on the immune function of Chinese elite short-track speed skaters.
Li T, Shao J, An N, Chang Y, Xia Y, Han Q, Zhu F. Li T, et al. Immun Inflamm Dis. 2024 Oct;12(10):e70030. doi: 10.1002/iid3.70030. Immun Inflamm Dis. 2024. PMID: 39352112 Free PMC article. - Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury.
Ruscitti C, Abinet J, Maréchal P, Meunier M, de Meeûs C, Vanneste D, Janssen P, Dourcy M, Thiry M, Bureau F, Schneider C, Machiels B, Hidalgo A, Ginhoux F, Dewals BG, Guiot J, Schleich F, Garigliany MM, Bellahcène A, Radermecker C, Marichal T. Ruscitti C, et al. Sci Immunol. 2024 Aug 2;9(98):eado1227. doi: 10.1126/sciimmunol.ado1227. Epub 2024 Aug 2. Sci Immunol. 2024. PMID: 39093958 Free PMC article. - Matricellular proteins in immunometabolism and tissue homeostasis.
Eun K, Kim AY, Ryu S. Eun K, et al. BMB Rep. 2024 Sep;57(9):400-416. doi: 10.5483/BMBRep.2023-0156. BMB Rep. 2024. PMID: 38919018 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous